Northrop Grumman Corp. ((NOC)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Northrop Grumman Signals Confidence With Record Backlog and Cash Surge in Latest Earnings Call
Northrop Grumman’s latest earnings call struck an upbeat tone, as management emphasized record backlog, strong Q4 and full‑year performance, and particularly robust free cash flow. While they acknowledged timing risks in some major programs and near‑term margin pressure in Aeronautics, the overall message was one of solid operational execution and disciplined, capacity‑driven investment. The combination of strong demand, rising international orders, and substantial cash generation left management sounding confident about the company’s trajectory, even as they framed 2026 guidance conservatively.
Record Backlog and Strong Awards Pipeline
Northrop Grumman highlighted a new company record backlog of more than $95 billion, later referenced as $96 billion, underpinned by roughly $46 billion in net awards in 2025 and nearly $20 billion of backlog growth since 2021. Management underscored a five‑year average book‑to‑bill ratio of 1.1x, indicating that contract wins have consistently outpaced revenue recognition. This deep backlog provides multi‑year visibility on growth, spanning key strategic programs across air, space, and defense, and positions the company to benefit from elevated U.S. and allied defense spending for years to come.
Revenue Growth and Fourth-Quarter Strength
The company closed the year with a strong sales performance. Fourth quarter revenue reached $11.7 billion, up 10% year over year and accelerating 12% sequentially, with Q4 accounting for 28% of full‑year sales. For 2025, sales were about $42 billion, representing roughly 3% organic growth and coming in above the high end of prior guidance. Management framed this as evidence that execution is improving across programs and that supply chain and labor dynamics are stabilizing, allowing more of the company’s sizable backlog to convert into revenue.
Earnings and Free Cash Flow Outperformance
Profitability and cash generation were clear bright spots. Q4 mark‑to‑market adjusted EPS rose 13% year over year to $7.23, reflecting both higher sales and disciplined cost control. Full‑year free cash flow reached $3.3 billion, up 26% versus 2024 and marking the third consecutive year of at least 25% free cash flow growth. Management emphasized that this strong cash generation gives Northrop Grumman flexibility to fund capacity expansions, manage the balance sheet, and continue shareholder returns, even as they choose to lean more heavily into growth investments near term.
Momentum in Aeronautics and Mission Systems
Aeronautics Systems emerged as a key growth driver in the quarter, posting Q4 sales of $3.9 billion, up 18% year over year, making it the fastest‑growing segment. Mission Systems also delivered double‑digit growth in Q4, and management guided this business toward high‑$12 billion in sales by 2026, with segment margins moving into the high‑14% range. Together, these businesses underscore Northrop’s strength in advanced aircraft, sensors, and mission‑critical electronics, and they remain central to the company’s strategy as demand rises for high‑end defense capabilities.
Space Business Recovery and Strategic Wins
The Space segment returned to growth in Q4, with sales up 5% year over year, reversing prior softness. Growth was driven by Gen 63 motors supporting a large commercial LEO constellation and by classified programs. The company secured awards for 18 additional Tranche 3 satellites under the Space Development Agency program, lifting its SDA satellite backlog to 150 units, and won Gen 63 orders that underpin multi‑year deliveries. These wins support a more durable growth profile in space and reinforce Northrop’s position in the emerging proliferated satellite architecture market.
Defense Systems and Munitions Capacity Expansion
Defense Systems posted broad‑based growth, with Q4 revenue up 7% on a GAAP basis and 12% organically. Management zeroed in on munitions as a major strategic focus, noting that tactical solid rocket motor capacity has already doubled since 2021. Plans are in place to increase capacity at the ABL facility by another 50% by early 2027 and to triple capacity at Elkton by 2030. These expansions are intended to meet surging demand for munitions from the U.S. and allies and to position Northrop as a long‑term beneficiary of efforts to replenish and modernize the global munitions stockpile.
Accelerating International Growth
International markets are becoming an increasingly important growth engine. International sales grew 20% in 2025, reflecting heightened demand from allies across multiple regions. Management reported formal requests from more than 20 countries for its integrated air and missile defense solutions and expects multiple contract opportunities across the Americas, the Middle East, and Asia‑Pacific. This expanding international footprint diversifies the revenue base beyond the U.S. Department of Defense and provides another lever for sustained top‑line growth.
Strengthened Pension Position and Disciplined Capital Plan
The company’s balance sheet and pension profile were another source of comfort for investors. Pension asset returns of 11.3% in 2025 improved the plan’s funding status to 106%, implying minimal required pension cash contributions going forward. Northrop plans to increase capital expenditures to $1.65 billion in 2026—about 4% of sales—to fund manufacturing capacity and key infrastructure. Even with higher CapEx, management is targeting free cash flow of $3.1–$3.5 billion, underscoring the company’s ability to invest heavily while maintaining strong cash returns.
Conservative 2026 Guidance Leaves Upside Optionality
Management characterized its 2026 guidance as prudent and notably conservative, particularly because it excludes potential upside from a B‑21 production‑rate acceleration and certain other opportunities. The company is guiding to sales of $43.5–$44.0 billion, a mid‑single‑digit percentage increase, with growth expected to build as the year progresses. This conservatism is tied largely to the timing of backlog conversion and uncertainties around the ramp of specific programs. For investors, this implies that realized results could exceed the current outlook if large programs move faster than assumed.
B-21 Acceleration Would Demand Heavy Upfront Investment
While the B‑21 bomber is a marquee program for Northrop Grumman, management stressed that any acceleration in production would come with sizable upfront costs. They estimate that increasing production rates would require $2–$3 billion of investment spread over several years, with most of the financial and volume benefits accruing in the 2027–2029 timeframe rather than materially impacting 2026. This framing is important for investors: even if a faster B‑21 ramp is approved, the near‑term effect would likely be more capital intensity and development mix, with a payoff further out.
Sentinel Program Timing Uncertainty
The Sentinel intercontinental ballistic missile replacement program remains in development for several more years, with production not expected until later in the decade. Questions on the call referenced a pushed‑out initial operational capability timeline into the next decade, underscoring the program’s long‑duration profile and execution risk. As a result, Sentinel is not expected to be a major revenue contributor in the near term, and its timing adds another layer of uncertainty to backlog conversion in the mid‑2030s rather than immediate growth.
Aeronautics Margins Pressured by Development Mix
Despite strong top‑line growth, Aeronautics margins are expected to remain under pressure. For 2026, the segment is guided to low‑to‑mid single‑digit sales growth with operating margin in the low‑to‑mid 9% range. The main headwind is mix: a higher proportion of development programs such as the B‑21 and other advanced platforms dampens margins compared with mature production work. Management framed this as a strategic tradeoff—accepting lower near‑term profitability to secure and execute on high‑value, long‑cycle programs that can yield better economics over time.
Program-Level Variability and EAC Adjustments
The call highlighted some program‑level noise that impacted quarterly results, particularly in Defense Systems. Operating income in that segment was modestly down in the quarter mainly due to fewer favorable estimate‑at‑completion (EAC) adjustments, even as sales grew. Additionally, certain volumes, such as Gen 63 motors, are expected to be roughly flat in 2026 as capacity expansions come online, creating year‑to‑year variability. Management framed these effects as normal in a portfolio of complex programs and stressed that the broader demand backdrop remains strong.
Capital Allocation Prioritizes Investment Over Buybacks
Northrop Grumman signaled a clear shift in capital allocation toward investment in the industrial base rather than aggressive share repurchases. Management plans to keep the share count roughly flat and does not expect additional buybacks beyond the end of January. Instead, the company is channeling more cash into CapEx and capacity expansions, particularly in munitions and other constrained areas. While this may temper near‑term per‑share growth from buybacks, it is intended to enhance long‑term earnings power and resilience.
Seasonality and a Slower Start to 2026
Investors were cautioned to expect a softer start to the year. Q1 2026 sales are projected to be up only low single digits, reflecting fewer working days (61 in the quarter) and some material deliveries that boosted Q4 2025 but will not repeat. This creates a front‑loaded seasonality effect, with growth expected to accelerate through the remaining quarters. Management emphasized that this timing dynamic does not change the full‑year outlook but is important context for near‑term expectations.
Forward-Looking Guidance Highlights Steady Growth and Strong Cash
For 2026, Northrop Grumman is guiding to sales of $43.5–$44.0 billion, representing mid‑single‑digit growth and a trajectory of accelerating revenue as the year progresses. Segment operating income is expected between $4.85 billion and $5.0 billion, implying a low‑ to mid‑11% segment operating margin, with mark‑to‑market adjusted EPS projected at $27.40–$27.90, also up mid‑single digits. The outlook assumes an effective tax rate in the low‑ to mid‑17% range, interest expense around $620 million, and approximately $280 million in other corporate costs, with a largely flat share count. Free cash flow is forecast at $3.1–$3.5 billion, even as capital expenditures rise to $1.65 billion (about 4% of sales) to fund capacity additions. Segment guidance calls for mid‑$13 billion in Aeronautics sales with low‑to‑mid‑9% margins, mid‑to‑high $8 billion in Defense Systems at roughly 10% margins, high‑$12 billion in Mission Systems with margins in the high‑14% range, and roughly $11 billion in Space at around 11% margins, alongside intersegment eliminations of about $2.4 billion. Management reiterated a disciplined capital deployment approach, including debt repayment and board‑determined dividends, supported by a well‑funded pension and expected cash recoveries.
In closing, Northrop Grumman’s earnings call painted a picture of a defense contractor with strong demand visibility, record backlog, and powerful cash generation, offset by normal program timing risks and intentional near‑term investment. International growth, munitions capacity expansion, and recovering space activity add multiple layers of upside to the story, while conservative 2026 guidance leaves room for positive surprises if key programs ramp faster than expected. For investors, the message was one of steady, cash‑rich growth with management choosing to prioritize long‑term capability and scale over maximal near‑term financial engineering.

